Bifidobacterium animalis subsp. lactis HN019 and Reduced Antimicrobial Use

• Comparison of two probiotics in follow-on formula: Bifidobacterium animalis subsp. lactis HN019 reduced upper respiratory tract infections in Chinese infants.

  • 2022-10-04
  • RCT · n = 192
  • Beneficial Microbes 13(4)
  • • J. Dekker
    • M. Quilter
    • H. Qian

  • PubMed: 36004715
  • DOI: 10.3920/BM2022.0041

  6 Insights on

  • Reduced Antimicrobial Use

  • High evidence

  No infants in the HN019 group were prescribed antibiotics or antivirals, compared with 3 (4.7%) in the HN001 group and 7 (10.9%) in the control group.

  Effect

  Beneficial

  Effect size

  Moderate

  Dose

  10^6 cfu/g